AstraZeneca Amends China Collaboration Agreement With Ironwood

Date : 09/18/2019 @ 6:46AM
Source : Dow Jones News
Stock : Astrazeneca Plc (AZN)
Quote : 7407.0  190.0 (2.63%) @ 1:55PM
Astrazeneca share price Chart

AstraZeneca Amends China Collaboration Agreement With Ironwood

Astrazeneca (LSE:AZN)
Historical Stock Chart

3 Months : From Sep 2019 to Dec 2019

Click Here for more Astrazeneca Charts.
   By Adria Calatayud 

AstraZeneca PLC (AZN.LN) said Wednesday that it will assume sole responsibility for developing, manufacturing and commercializing Ironwood Pharmaceuticals Inc.'s (IRWD) Linzess drug in China after amending a collaboration agreement.

The FTSE 100-listed company said Cambridge, Mass.-based biotech company Ironwood will no longer be involved in the research and development or the commercialization of Linzess, a treatment for patients with irritable bowel syndrome with constipation, and that manufacturing responsibility will also be transferred to AstraZeneca.

The two companies entered into a collaboration pact in 2012, AstraZeneca said. Under the original agreement, both companies were jointly responsible for strategic oversight of the development and commercialization of Linzess in China, while AstraZeneca had primary responsibility for local operational execution.

Linzess was approved by China's National Medical Products Administration for adults with irritable bowel syndrome with constipation in January and is expected to be launched later this year, AstraZeneca said.


Write to Adria Calatayud at


(END) Dow Jones Newswires

September 18, 2019 02:31 ET (06:31 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20191216 14:10:18